ZA966083B - Agent for transdermal administration containing esters of 13-ethyl-17ß-hydroxy-11-methylene-18,19-dinor-17Ó-pregn-4-en-20-yn-3-one. - Google Patents
Agent for transdermal administration containing esters of 13-ethyl-17ß-hydroxy-11-methylene-18,19-dinor-17Ó-pregn-4-en-20-yn-3-one.Info
- Publication number
- ZA966083B ZA966083B ZA9606083A ZA966083A ZA966083B ZA 966083 B ZA966083 B ZA 966083B ZA 9606083 A ZA9606083 A ZA 9606083A ZA 966083 A ZA966083 A ZA 966083A ZA 966083 B ZA966083 B ZA 966083B
- Authority
- ZA
- South Africa
- Prior art keywords
- dinor
- pregn
- methylene
- hydroxy
- ethyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0096—Alkynyl derivatives
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19526789 | 1995-07-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA966083B true ZA966083B (en) | 1998-06-19 |
Family
ID=7767510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9606083A ZA966083B (en) | 1995-07-17 | 1996-07-17 | Agent for transdermal administration containing esters of 13-ethyl-17ß-hydroxy-11-methylene-18,19-dinor-17Ó-pregn-4-en-20-yn-3-one. |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE19613698A1 (en) |
ZA (1) | ZA966083B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7323454B2 (en) | 2002-05-30 | 2008-01-29 | N.V. Organon | Etonogestrel esters |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10019171A1 (en) * | 2000-04-07 | 2001-10-18 | Schering Ag | Compositions for use as penetration enhancers in transdermal formulations for highly lipophilic active ingredients |
DE10211832A1 (en) * | 2002-03-16 | 2003-10-02 | Lohmann Therapie Syst Lts | Hormone-containing transdermal therapeutic system with a drug reservoir based on vinyl acetate-vinylpyrrolidone copolymer with improved cohesion |
-
1996
- 1996-04-01 DE DE19613698A patent/DE19613698A1/en not_active Withdrawn
- 1996-07-17 ZA ZA9606083A patent/ZA966083B/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7323454B2 (en) | 2002-05-30 | 2008-01-29 | N.V. Organon | Etonogestrel esters |
Also Published As
Publication number | Publication date |
---|---|
DE19613698A1 (en) | 1997-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA962536B (en) | Pharmaceutical composition for transdermal administration. | |
AU4809596A (en) | Nanosuspensions for intravenous administration | |
HU9603495D0 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, as pharmaceutical agents | |
ZA9610729B (en) | Transdermal device for the delivery of flurbiprofen. | |
ZA965190B (en) | Pharmaceutical composition. | |
AU5397996A (en) | Iontophoretic transdermal system for the administration of at least two substances | |
ZA965866B (en) | 6-Dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients | |
ZA964337B (en) | Pharmaceutical compositions containing irbesartan. | |
CY2369B1 (en) | Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same. | |
AU3136897A (en) | Compositions, methods and devices for the transdermal delivery of drugs | |
AU693802B2 (en) | Agent for transdermal application containing gestoden esters | |
ZA967546B (en) | Pharmaceutical formulation. | |
AU7590096A (en) | Drug composition | |
AU6611396A (en) | New oxazolidinone derivatives, processes for the production thereof and pharmaceutical agents containing these compounds | |
AU5108196A (en) | Imidazoquinazolines, drugs containing these compounds, their use and process for their preparation | |
EP0581587A3 (en) | Base for transdermal administration. | |
ZA968081B (en) | Pharmaceutical composition. | |
EP0683668A4 (en) | Compositions and methods for transdermal drug delivery. | |
NZ308516A (en) | Transdermal therapeutic system (tts) for administering testosterone | |
ZA968905B (en) | Transdermal therapeutic system (tts) for administering active substances for drug dependence or drug addiction | |
HUT75029A (en) | Systems for controlled release of pilocarpine, and semipermeable capsule containing the active ingredient | |
ZA96796B (en) | Transdermal formulation. | |
ZA966842B (en) | Transdermal administration of vorozole. | |
ZA962752B (en) | Rate-controlled transdermal administration of risperidone. | |
MX9709453A (en) | Oral pharmaceutical composition of piperidinoalkanol compounds in solution form. |